04/25/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
04/05/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form POS AM | |
04/05/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2024
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
8:30 AM | Can-Fite BioPharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
|
03/28/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
6:27 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
6:06 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
2:32 PM | ARMISTICE CAPITAL, LLC (Filed by)
Can-Fite BioPharma (Subject)
| Form SC 13G | |
01/30/2024
6:24 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
12/28/2023
3:16 PM | Can-Fite BioPharma (Filer)
| Form F-3/A | |
12/20/2023
6:09 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/04/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/30/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
3:20 PM | Can-Fite BioPharma (Filer)
| Form 424B3 | |
11/21/2023
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2023
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023
6:11 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2023
6:01 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2023
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
09/10/2023
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
09/07/2023
6:25 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
09/01/2023
3:16 PM | Can-Fite BioPharma (Filer)
| Form POS AM | |
08/31/2023
6:12 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/24/2023
6:19 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2023
6:06 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2023
6:11 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023
6:10 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2023
6:08 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
06/01/2023
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023
6:14 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
